People · Operator
Named in public records as an officer, director or promoter · active 2018–2021 · Biotech / Pharma, Biotechnology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pillar Biosciences Inc. | — | Biotech / Pharma | Series B | $20.0M | $511.7M | 2021 |
| Pillar Biosciences, Inc. | — | Biotechnology | Series B | $18.0M | $715.6M | 2020 |
| AffyImmune Therapeutics, Inc. | — | Pharma | Series A | $7.9M | $243.4M | 2018 |
Gang Song at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gang Song on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Zhaohui Wang | 2 | 3 |
| Hong Fang Song | 2 | 2 |
| Shawn Liu | 2 | 2 |
| Hui Yang | 2 | 2 |
| Robert Forrester | 1 | 4 |
| Eric Lai | 1 | 1 |
| Hong Fang Sang | 1 | 1 |
| Moonsoo Jin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.